Inventor · disambiguated record
Xiao Shang
Also filed as: SHANG XIAO
4 granted patents·12 pending applications·32 citations·filing 2003–2024
73Inventor score
Files withCAI SHAOPEI4PROFOUNDBIO US CO4NOVARTIS VACCINES & DIAGNOSTIC3CHIRON CORP2BEIJING SHENOGEN PHARMA GROUP LTD1
Top patents by PatentIndex Score
16 records- 0183US7825132B2Inhibition of FGFR3 and treatment of multiple myelomaNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Nov 2, 2010·19 cites·9 claims
- 0278US8614216B2Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid saltsOKHAMAFE AUGUSTUS O·Filed 2012·Granted Dec 24, 2013·8 cites·27 claims
- 0375US2024245796A1Linkers, drug linkers and conjugates thereof and methods of using the samePROFOUNDBIO US CO·Filed 2024·Application pending·0 cites
- 0475US2024261427A1Linkers, drug linkers and conjugates thereof and methods of using the samePROFOUNDBIO US CO·Filed 2024·Application pending·0 cites
- 0573US2024207429A1Linkers, drug linkers and conjugates thereof and methods of using the samePROFOUNDBIO US CO·Filed 2023·Application pending·0 cites
- 0673US2024207418A1Linkers, drug linkers and conjugates thereof and methods of using the samePROFOUNDBIO US CO·Filed 2023·Application pending·0 cites
- 0767US7838527B2Methods of treating cancer and related methodsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Nov 23, 2010·5 cites·47 claims
- 0865US2009181979A1Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical propertiesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2009·Application pending·0 cites
- 0960US2014303182A1Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical propertiesCAI SHAOPEI·Filed 2014·Application pending·0 cites
- 1059US2013338171A1Pharmaceutically Acceptable Salts of Quinolinone Compounds Having Improved Pharmaceutical PropertiesCAI SHAOPEI·Filed 2013·Application pending·0 cites
- 1157US2005209247A1Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical propertiesCHIRON CORP·Filed 2004·Application pending·0 cites
- 1257US2005137399A1Methods for synthesizing quinolinone compoundsCHIRON CORP·Filed 2004·Application pending·0 cites
- 1356US2012277434A1Methods for synthesizing quinolinone compoundsCAI SHAOPEI·Filed 2012·Application pending·0 cites
- 1455US2013018058A1Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical propertiesCAI SHAOPEI·Filed 2011·Application pending·0 cites
- 1549US2011178097A1Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid saltsNOVARTIS AG·Filed 2006·Application pending·0 cites
- 1647US10233249B2Antibodies and methods for treating estrogen receptor-associated diseasesBEIJING SHENOGEN PHARMA GROUP LTD·Filed 2014·Granted Mar 19, 2019·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Xiao Shang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →